ASRM 75Th Scientific Congress – POSTERS Tuesday, October 15
Total Page:16
File Type:pdf, Size:1020Kb
Click on the th PosterPlus ASRM 75 Scientific Congress – POSTERS button in the ASRM meeting Tuesday, October 15, 2019 • 6:30 AM – 7:45 AM app to see bonus content for participating PCC Expo Hall, Poster Area poster presenters. ACCESS TO CARE P-71 EMBRYO EUPLOIDY RATES DIFFER IN SAME-SEX MALE COUPLES UTILIZING A SINGLE OVUM P-136 RELATIONSHIP BETWEEN THE PREGNANCY AND THE SIZE OF ARRESTED BLASTOMERE P-1 DOES AN INSURANCE MANDATE TO COVER INFERTILITY TREATMENT INCREASE ACCESS TO IN DONOR. N. E. Ramos DERIVED FROM ABNORMAL CYTOKINESIS IN BLASTOCYST TRANSFER CYCLES. H. Izumi VITRO FERTILIZATION? K. Payne P-72 ANEUPLOIDY RATE IN BRCA CARRIERS IS SIMILAR TO AGE-MATCHED INFERTILE WOMEN. M. P-137 EMBRYO SELECT ASSAY: A NON-INVASIVE, DIPSTICK ELISA STRIP ASSAY TO IDENTIFY THE MOST P-2 DEFINING INFERTILITY: HOW THE LANGUAGE USED TO DESCRIBE INFERTILITY SHAPES PUBLIC Facadio Antero COMPETENT EMBRYO FROM THE COHORT. E. E. Puscheck PERCEPTION AND POLICY. A. C. Mancuso P-73 SUBOPTIMAL STIMULATION IS PREDICTIVE OF INCREASED ANEUPLOIDY AND REDUCED P-138 SINGLE VITRIFIED-WARMED BLASTOCYST TRANSFER: WHAT ARE THE BEST PREDICTIVE P-3 PATIENT ACCESS AND UNTAPPED POTENTIAL: CAN NEW DATA DRIVE PROGRESS? H. Taske PREGNANCIES PER CYCLE START. J. B. Whitney FACTORS FOR SUCCESS? E. Boulet P-4 GENDER AND FERTILITY STATUS AFFECT PERCEPTIONS OF INFERTILITY AND SUPPORT FOR FERTILITY PRESERVATION P-139 MATURITY OF CUMULUS OOCYTE COMPLEX (COC) PREDICTS THE OUTCOME OF ART. ~ FOCUS ACCESS TO CARE: A CROSS SECTIONAL STUDY. R. K. Chung P-74 ESTIMATES OF INFERTILITY IN AN ERA OF INCREASING STI RATES, 2002-2015. M. Snow ON DYSMATURE ~ M. Amita P-5 VARIATION IN AVAILABILITY OF FERTILITY CARE TREATMENTS ACROSS US REGIONS. L. B. Ramirez P-75 FERTILITY PRESERVATION FOR SOCIAL REASONS IN A POPULATION OF OLDER WOMEN. ¿MYTH P-140 THE PREDICTIVE VALUE OF DAY 5 MORPHOLOGY FOR SLOW DEVELOPING EMBRYOS. J. Chervenak P-6 NATIONWIDE SURVEY OF ACCESS TO CARE INITIATIVES IN REI PRACTICES ASSOCIATED WITH OR REALITY? R. J. Osés IVF OUTCOME PREDICTORS - ENDOMETRIUM OB/GYN RESIDENCY PROGRAMS. T. Jackson-Bey P-76 THE QUANTIFICATION OF RESIDUAL CRYOPROTECTANTS IN THE THAWED OVARIAN TISSUE P-141 ENDOMETRIAL THICKNESS IN PREDICTION OF PREGNANCY OUTCOME IN FRESH EGG CANCER FOR OVARIAN TISSUE TRANSPLANTATION. Y. Sugishita DONATION CYCLES: A RETROSPECTIVE COHORT ANALYSIS. E. Bosch P-7 ONCOLOGIC OOCYTE CRYOPRESERVATION FOR FERTILITY PRESERVATION: NATIONAL TRENDS P-77 EMPLOYER-BASED INSURANCE COVERAGE DRAMATICALLY INCREASES UTILIZATION OF P-142 WHAT IS THE CLINICAL IMPACT OF THE ENDOMETRIAL RECEPTIVITY ARRAY IN PGT-A AND AND COMPARISON OF CYCLE CHARACTERISTICS BETWEEN WOMEN WITH AND WITHOUT PLANNED OOCYTE CRYOPRESERVATION. A. S. Yeshua OOCYTE DONATION CYCLES? F. Martinez CANCER. J. F. Kawwass P-78 OOCYTE VITRIFICATION FOR ANTICIPATED GAMETE EXHAUSTION (AGE -BANKING) - A P-143 INTENTIONAL ENDOMETRIAL INJURY TRYING TO IMPROVE CLINICAL OUTCOMES OF P-8 RISK FACTORS FOR ATYPICAL HYPERPLASIA AND ENDOMETRIAL CANCER IN THE INFERTILITY SYSTEMATIC REVIEW AND META-ANALYSIS OF SOCIAL TRENDS AND EFFICACY. S. Baram AN OOCYTE DONATION PROGRAM IN PATIENTS WITHOUT RIF. INTERYM ANALYSIS OF A POPULATION: A CASE-CONTROL STUDY. J. L. Kahn P-79 FERTILITY PRESERVATION: FROZEN IN TIME? S. R. Baum RANDOMIZED CONTROLLED TRIAL. C. Vidal P-9 UTILIZATION OF GONADOTROPIN-RELEASING HORMONE AGONISTS FOR PRESERVATION OF P-80 PROVIDING PATIENTS WITH SUBSIDIZED FERTILITY PRESERVATION SERVICES IMPROVES P-144 DO PATIENTS WITH A HISTORY OF CHRONIC ENDOMETRITIS BENEFIT FROM OVARIAN FUNCTION IN WOMEN WITH BREAST CANCER RECEIVING CHEMOTHERAPY. S. F. Vitez ACCESS TO CARE. L. T. Bouchard CORTICOSTEROIDS AND ANTIBIOTICS BEFORE FROZEN EMBRYO TRANSFER? N. D. Yoder P-10 EVIDENCE THAT ALKYLATING CHEMOTHERAPY IS NOT RELATED TO CLINICAL INFERTILITY IN P-81 SPERM CRYOPRESERVATION FOR FERTILITY PRESERVATION IN MEN WITH NON-MALIGNANT P-145 IS THERE AN ASSOCIATION BETWEEN ENDOMETRIAL THICKNESS AT TIME OF FROZEN EMBRYO ADOLESCENT AND YOUNG ADULT (AYA) CANCER SURVIVORS. K. Pinson DISEASES. T. Takeshima TRANSFER AND THE INCIDENCE OF SUBCHORIONIC HEMATOMA OR VAGINAL BLEEDING? S. Chang P-11 REPRODUCTIVE POTENTIAL OF VITRIFIED OOCYTES AND EMBRYOS PRODUCED FROM IN VITRO P-82 EQUAL OPPORTUNITY FOR ALL? AN ANALYSIS OF RACE AND ETHNICITY IN FERTILITY P-146 ENDOMETRIAL PREPARATION WITH ETANERCEPT INCREASES EMBRYO IMPLANTATION MATURATION CYCLES OF CANCER PATIENTS FOR FERTILITY PRESERVATION. W. Son PRESERVATION (FP) IN A MAJOR AMERICAN CITY P. E. Voigt AND LIVE BIRTH IN WOMEN SUFFERING FROM IMPLANTATION FAILURE DURING IN VITRO P-12 FEASIBILITY OF FERTILITY PRESERVATION IN PRE-PUBERTAL MALES SCHEDULED TO RECEIVE P-83 WHAT IS IMPORTANT TO WOMEN CONSIDERING FERTILITY PRESERVATION BEFORE CANCER FERTILIZATION. K. Y. Santiago CHEMOTHERAPY. H. L. Bernie TREATMENT? COMPARING DECISION-MAKING VALUES WITH AND WITHOUT USING THE P-147 CHRONIC ENDOMETRITIS SCREENING IN PATIENTS WHO EXPERIENCE EUPLOID EMBRYO P-13 FERTILITY PRESERVATION DISCUSSION IN CANCER PATIENTS IS UNDERUTILIZED AND VARIES PATHWAYS PATIENT DECISION AID WEBSITE S. Campbell IMPLANTATION FAILURE DOES NOT IMPROVE IVF OUTCOMES AFTER A SUBSEQUENT EUPLOID BASED ON AGE. P. N. Dietrich P-84 ELECTIVE OOCYTE CRYOPRESERVATION COUNSELING TOOL BASED ON NEXT GENERATION FET. C. Hernandez-Nieto P-14 FERTILITY-SPARING TREATMENT (FST) AND ASSISTED REPRODUCTIVE TECHNOLOGY (ART) SEQUENCING RESULTS. M. Miguens P-148 VALUE OF ENDOMETRIAL ECHO PATTERN TRANSFORMATION AFTER HCG TRIGGER IN IN PATIENTS WITH ENDOMETRIAL CARCINOMA (EMCA) AND ENDOMETRIAL INTRAEPITHELIAL INVITRO OOCYTE MATURATION PREDICTING IVF PREGNANCY OUTCOME: A PROSPECTIVE COHORT STUDY. Y. Li NEOPLASIA (EIN): PREGNANCY OUTCOMES AFTER EMBRYO TRANSFER (ET). H. Friedlander P-85 ENHANCING REPRODUCTIVE OPPORTUNITIES: THE BIOLOGIC POTENTIAL OF VITRIFIED IN- P-149 CLINICAL UTILITY OF THE ENDOMETRIAL RECEPTIVITY ARRAY IN WOMEN WITH PRIOR FAILED P-15 OVARIAN STIMULATION IN CANCER PATIENTS: RANDOM VERSUS CONVENTIONAL START. A. N. Coscia VITRO MATURED OOCYTES. C. Hernandez-Nieto TRANSFERS. L. E. Eisman P-16 ADDED BENEFIT OF IMMATURE OOCYTE MATURATION FOR FERTILITY PRESERVATION IN P-86 SUPPLEMENTING IN-VITRO MATURATION MEDIA WITH HUMAN FOLLICULAR FLUID IMPROVES P-150 WITHDRAWN WOMEN WITH MALIGNANCY. Y. Cohen BOTH THE MATURATION RATE OF MOUSE IMMATURE OOCYTES AND THE SUBSEQUENT P-151 PROGNOSTIC VALUE OF UTERINE NATURAL KILLER (UNK) CELLS DENSITY IN PERI-IMPLANTATION P-17 ACCESS TO FERTILITY-SPARING TREATMENT OF ENDOMETRIAL INTRAEPITHELIAL NEOPLASIA: EMBRYONIC DEVELOPMENT. T. Horikawa ENDOMETRIUM FROM WOMEN WITH RECURRENT IMPLANTATION FAILURE. X. Chen REPRODUCTIVE OUTCOMES AND PATIENT SATISFACTION. M. Shear P-87 IN VITRO OOCYTE MATURATION (IVM) IS A SUCCESSFUL ART OPTION FOR PCOS PATIENTS. P-152 IMPACT OF ENDOMETRIAL PREPARATION IN CRYOPRESERVED-WARMED EMBRYO TRANSFER P-18 LETROZOLE AND FERTILITY PRESERVATION IN PATIENTS WITH BREAST CANCER. M. Braham T. Schlenker (FET) CYCLES ON PERINATAL OUTCOME. A. Sokalska CRYOPRESERVATION P-88 THE TIMING OF THE RELEASE OF THE FIRST POLAR BODY PREDICTS THE CLEAVAGE RATE P-153 SUBENDOMETRIAL JUNCTION ZONE THICKNES: IMPACT ON IVF OUTCOMES IN AN OOCYTE P-19 OOCYTE YIELD WITH IMMEDIATE SUBSEQUENT OOCYTE CRYOPRESERVATION (OC) CYCLES AFTER PARTHENOGENETIC ACTIVATION FOR HUMAN OOCYTES OBTAINED BY IN VITRO RECEPTOR PROGRAM. F. Galera Fernandez COMPARED TO INTERVAL CYCLES. B. L. Maslow MATURATION. H. Shirasawa IVF OUTCOME PREDICTORS - GESTATIONAL CARRIERS P-20 INITIAL VALIDATION OF AN AUTOMATED CRYOSTORAGE AND INVENTORY MANAGEMENT P-89 EMBRYOLOGIST FRIENDLY PROGRAMMED IVM WITH DELAYED BLASTOCYST TRANSFER. B. I. Rose P-154 CAN BIRTH WEIGHT AND GESTATIONAL AGE AT DELIVERY OF SINGLETON GESTATIONAL SYSTEM. T. A. Sharp IVF OUTCOME PREDICTORS - AGE CARRIER PREGNANCIES BE PREDICTED BY THE GESTATIONAL CARRIER’S OWN PREVIOUS P-21 CRYOPRESERVATION OF BOTH MALE AND FEMALE GAMETES LEADS TO REDUCED EMBRYO P-90 INCREASED PATERNAL AGE IS ASSOCIATED WITH DECREASED BLASTULATION AND EUPLOID SINGLETON PREGNANCIES? R. S. Mandelbaum DEVELOPMENT AND IMPLANTATION POTENTIAL. D. P. Braga RATES BUT NOT PREGNANCY OUTCOMES IN THE SETTING OF A EUPLOID SINGLE EMBRYO P-155 WITHDRAWN P-22 AUTOMATED VITRIFICATION FOR EMBRYO CRYOPRESERVATION: PRELIMINARY COMPARATIVE TRANSFER. B. M. Hanson P-156 PREGNANCY RATES FOLLOWING SINGLE EUPLOID EMBRYO TRANSFER ARE UNCHANGED IN RESULTS AND FIRST LIVE BIRTH IN EUROPE. M. Dal Canto P-91 ADVANCED PATERNAL AGE IS ASSOCIATED WITH AN INCREASED RISK FOR SEGMENTAL GESTATIONAL CARRIER COMPARED TO NON-GESTATIONAL CARRIER IN VITRO FERTILIZATION P-23 PROLONGED SEMEN CRYOPRESERVATION DECREASES MOTILE CONCENTRATION. R. Simbulan ABERRATIONS IN EMBRYOS DERIVED FROM YOUNG OOCYTE DONORS. M. Dviri CYCLES. C. Riestenberg P-24 EMBRYOS FROZEN WITHIN A SHORT TIME OF REACHING THE EXPANDED BLASTOCYSTS P-92 CLINICAL PREGNANCY OUTCOME ACCORDING TO AGE OF PATIENTS WITH HIGH PROPORTION IVF OUTCOME PREDICTORS - HORMONE LEVELS FROM THE EARLY BLASTOCYSTS HAVE HIGH VIABILITY: TIME-LAPSE INVESTIGATION OF 5177 OF FAILED OOCYTE MATURATION IN ICSI CASES. Y. Park P-157 THE EFFECT OF SUPRAPHYSIOLOGIC ESTRADIOL LEVELS ON PREGNANCY OUTCOMES IN BLASTOCYSTS. Y. Kobayashi IVF OUTCOME PREDICTORS - EMBRYO CULTURE SINGLE EUPLOID FROZEN EMBRYO TRANSFER CYCLES. S. Chang P-25 THE TWO-STEP ASYNCHRONOUS VITRIFIED-THAWED BLASTOCYST EMBRYO TRANSFER P-93 IS THE NUMBER OF BLASTOCYCT MORPHOLOGIC EVALUATIONS (BMA) ON DAY 6 CORRELATED P-158 AN ANALYSIS OF THE CONTRIBUTION OF SERUM ESTRADIOL LEVEL ON SUBCHORIONIC STRATEGY. THE IMPACT ON MULTIPLE PREGNANCY RATE. V. Veselovskyy WITH DAY 7 EMBRYONIC